RCT: Added Value of Coordinator for the Management of Hip Fracture Patients
Randomized Controlled Trial: Added Value of Coordinator for the Management of Hip Fracture Patients in a Network of Public Hospitals in Brussels.
1 other identifier
interventional
128
1 country
1
Brief Summary
Introduction: Hip fracture due to osteoporosis is associated with an extremely high mortality morbidity and loss of quality of life. The risk of future fracture after a first hip fracture is increased. Several studies reported that patients who suffered from a fracture are not optimally treated and do not receive osteoporosis treatment after the first fracture episode. Aim: To evaluate whether a coordinator increases the optimal management of osteoporotic fracture patients and hip fracture patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 5, 2013
CompletedFirst Posted
Study publicly available on registry
February 7, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFebruary 7, 2013
February 1, 2013
3 months
February 5, 2013
February 5, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
A score of optimal management of osteoporosis.
Definition of the score and management: 1. Realization of a bone density measurement. 2. Identification of secondary osteoporosis. 3. Identification of risk factors and calculation of the probability of a future fracture using FRAX score. 4. Attempt to correct risk factors of osteoporosis when possible. 5. Prevention of falls. 6. Prescription of calcium and vitamin D. 7. Prescription of a medical osteoporosis treatment. 8. Report to the general practitioner.
3-6 months
Secondary Outcomes (1)
New fractures.
2 years
Study Arms (2)
usual care
NO INTERVENTIONusual care
Added value of coordinator
OTHERAdded value of coordinator
Interventions
Eligibility Criteria
You may qualify if:
- Identification in the "IRIS public hospital network of all patients above 50 years" who suffer from hip fracture.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRIS Hospitals
Brussels, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 5, 2013
First Posted
February 7, 2013
Study Start
December 1, 2012
Primary Completion
March 1, 2013
Study Completion
December 1, 2014
Last Updated
February 7, 2013
Record last verified: 2013-02